Titre du document / Document title

Experience with zolpidem 'as needed' in primary care settings

Auteur(s) / Author(s)

HAJAK Göran ⁽¹⁾ ; GEISLER Peter ⁽¹⁾ ;

Affiliation(s) du ou des auteurs / Author(s) Affiliation(s)

⁽¹⁾ Department of Psychiatry and Psychotherapy, University of Regensburg, ALLEMAGNE

Résumé / Abstract

'As needed' non-nightly intake of hypnotic agents by patients suffering from chronic insomnia is likely to offer benefits such as maintained efficacy while preventing unnecessary long-term nightly use associated with the risk of tolerance and dependence. To date, three studies have proven the 'as needed' approach with zolpidem in patients with primary insomnia treated in outpatient practice. In total, more than 3000 primary care patients, proved that flexible or semi-flexible schedules of zolpidem 'as needed' treatment are feasible. In all the studies, 'as needed' zolpidem treatment was both effective and well tolerated by the patients. Moreover. the results of these studies clearly indicated that chronic insomniac patients are capable of limiting their hypnotic intake, showing no tendency to increase intake over time and even a trend to decreasing use of medication.

Revue / Journal Title

CNS drugs   ISSN 1172-7047 

Source / Source

Congrès
New Insights in Insomnia Management: Focus on Zolpidem. Satellite Symposium, Bangkok , THAILANDE (12/2000)
2004, vol. 18, SUP1 (50 p.)  [Document : 6 p.] (7 ref.), pp. 35-40 [6 page(s) (article)]

Langue / Language

Anglais

Editeur / Publisher

Adis International, Auckland, NOUVELLE-ZELANDE  (1994) (Revue)

Mots-clés anglais / English Keywords

Gabaergic agonist ; Gabaergic receptor A ; Agonist ; Sleep disorder ; Discontinuous ; Treatment withdrawal ; Human ; Treatment ; Chemotherapy ; Sedative ; Primary health care ; Hypnotic ; Zolpidem ; Insomnia ;

Mots-clés français / French Keywords

Imidazo pyridine dérivé ; Stimulant gabaergique ; Récepteur gabaergique A ; Agoniste ; Trouble sommeil ; Discontinu ; Arrêt traitement ; Homme ; Traitement ; Chimiothérapie ; Sédatif ; Soin santé primaire ; Hypnotique ; Zolpidem ; Insomnie ;

Mots-clés espagnols / Spanish Keywords

Estimulante gabaérgico ; Receptor gabaminérgico A ; Agonista ; Trastorno sueño ; Discontinuo ; Paro tratamiento ; Hombre ; Tratamiento ; Quimioterapia ; Sedante ; Cuidados salud primaria ; Hipnótico ; Zolpidem ; Insomnio ;

Localisation / Location

INIST-CNRS, Cote INIST : 26528, 35400011503142.0050